{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:48:28Z","timestamp":1787028508072,"version":"build-2736575974"},"reference-count":78,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"NIH","doi-asserted-by":"publisher","award":["R01DK125322"],"award-info":[{"award-number":["R01DK125322"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>For nearly five decades, cisplatin has played an important role as a standard chemotherapeutic agent and been prescribed to 10\u201320% of all cancer patients. Although nephrotoxicity associated with platinum-based agents is well recognized, treatment of cisplatin-induced acute kidney injury is mainly supportive and no specific mechanism-based prophylactic approach is available to date. Here, we postulated that systemically delivered rapamycin perfluorocarbon nanoparticles (PFC NP) could reach the injured kidneys at sufficient and sustained concentrations to mitigate cisplatin-induced acute kidney injury and preserve renal function. Using fluorescence microscopic imaging and fluorine magnetic resonance imaging\/spectroscopy, we illustrated that rapamycin-loaded PFC NP permeated and were retained in injured kidneys. Histologic evaluation and blood urea nitrogen (BUN) confirmed that renal structure and function were preserved 48 h after cisplatin injury. Similarly, weight loss was slowed down. Using western blotting and immunofluorescence staining, mechanistic studies revealed that rapamycin PFC NP significantly enhanced autophagy in the kidney, reduced the expression of intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1), as well as decreased the expression of the apoptotic protein Bax, all of which contributed to the suppression of apoptosis that was confirmed with TUNEL staining. In summary, the delivery of an approved agent such as rapamycin in a PFC NP format enhances local delivery and offers a novel mechanism-based prophylactic therapy for cisplatin-induced acute kidney injury.<\/jats:p>","DOI":"10.3390\/ijms24076086","type":"journal-article","created":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T03:50:21Z","timestamp":1679629821000},"page":"6086","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Rapamycin Perfluorocarbon Nanoparticle Mitigates Cisplatin-Induced Acute Kidney Injury"],"prefix":"10.3390","volume":"24","author":[{"given":"Qingyu","family":"Zhou","sequence":"first","affiliation":[{"name":"Taneja College of Pharmacy, University of South Florida, Tampa, FL 33620, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Quirk","sequence":"additional","affiliation":[{"name":"Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO 63110, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Hu","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Washington University School of Medicine, St. Louis, MO 63110, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Yan","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Washington University School of Medicine, St. Louis, MO 63110, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph P.","family":"Gaut","sequence":"additional","affiliation":[{"name":"Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA"},{"name":"Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1127-3699","authenticated-orcid":false,"given":"Christine T. N.","family":"Pham","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Washington University School of Medicine, St. Louis, MO 63110, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel A.","family":"Wickline","sequence":"additional","affiliation":[{"name":"Morsani College of Medicine, University of South Florida, Tampa, FL 33620, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Pan","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Washington University School of Medicine, St. Louis, MO 63110, USA"},{"name":"Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA"},{"name":"Department of Biomedical Engineering, Washington University in St. Louis, St. Louis, MO 63130, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,23]]},"reference":[{"key":"ref_1","unstructured":"NCI (2020, February 01). The \"Accidental\" Cure\u2014Platinum-based Treatment for Cancer: The Discovery of Cisplatin, Available online: https:\/\/www.cancer.gov\/research\/progress\/discovery\/cisplatin."},{"key":"ref_2","first-page":"191","article-title":"Clinical trials of cis-diamminedichloroplatinum (NSC-119875)","volume":"57","author":"Lippman","year":"1973","journal-title":"Cancer Chemother. Rep."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40620-017-0392-z","article-title":"Cisplatin nephrotoxicity: A review of the literature","volume":"31","author":"Manohar","year":"2018","journal-title":"J. Nephrol."},{"key":"ref_4","first-page":"924","article-title":"Nephrotoxicity of anticancer treatment","volume":"32","author":"Malyszko","year":"2017","journal-title":"Nephrol. Dial. Transpl."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2174\/1871520614666140127105809","article-title":"Anti-cancer agent-induced nephrotoxicity","volume":"14","author":"Fukasawa","year":"2014","journal-title":"Anticancer. Agents Med. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1056\/NEJMra1214243","article-title":"Acute kidney injury and chronic kidney disease as interconnected syndromes","volume":"371","author":"Chawla","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1681\/ASN.2013060610","article-title":"Long-term risk of coronary events after AKI","volume":"25","author":"Wu","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/ki.2011.405","article-title":"Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury","volume":"81","author":"Bucaloiu","year":"2012","journal-title":"Kidney Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.kint.2015.11.021","article-title":"Autophagy in acute kidney injury","volume":"89","author":"Kaushal","year":"2016","journal-title":"Kidney Int."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"710","DOI":"10.4161\/auto.6309","article-title":"Autophagy delays apoptosis in renal tubular epithelial cells in cisplatin cytotoxicity","volume":"4","author":"Kaushal","year":"2008","journal-title":"Autophagy"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/0008-5472.CAN-12-2464","article-title":"Chloroquine in cancer therapy: A double-edged sword of autophagy","volume":"73","author":"Kimura","year":"2013","journal-title":"Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000363677","article-title":"Autophagy in acute kidney injury and repair","volume":"127","author":"He","year":"2014","journal-title":"Nephron Clin. Pract."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"12006","DOI":"10.4238\/2015.October.5.13","article-title":"AMP-activated protein kinase regulates autophagic protection against cisplatin-induced tissue injury in the kidney","volume":"14","author":"Wei","year":"2015","journal-title":"Genet. Mol. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"619730","DOI":"10.3389\/fphys.2020.619730","article-title":"AMPK\/mTOR Signaling in Autophagy Regulation During Cisplatin-Induced Acute Kidney Injury","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Physiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ajpath.2011.11.001","article-title":"Autophagy guards against cisplatin-induced acute kidney injury","volume":"180","author":"Takahashi","year":"2012","journal-title":"Am. J. Pathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/ki.2012.261","article-title":"Autophagy in proximal tubules protects against acute kidney injury","volume":"82","author":"Jiang","year":"2012","journal-title":"Kidney Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1681\/ASN.2013040374","article-title":"New autophagy reporter mice reveal dynamics of proximal tubular autophagy","volume":"25","author":"Li","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"967826","DOI":"10.1155\/2014\/967826","article-title":"Pathophysiology of cisplatin-induced acute kidney injury","volume":"2014","author":"Ozkok","year":"2014","journal-title":"BioMed Res. Int."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev-med-050214-013407","article-title":"Acute Kidney Injury","volume":"67","author":"Zuk","year":"2016","journal-title":"Annu. Rev. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1074\/jbc.274.2.1058","article-title":"Regulation of translational effectors by amino acid and mammalian target of rapamycin signaling pathways. Possible involvement of autophagy in cultured hepatoma cells","volume":"274","author":"Shigemitsu","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cell.2009.03.046","article-title":"DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival","volume":"137","author":"Peterson","year":"2009","journal-title":"Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","article-title":"Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton","volume":"14","author":"Sarbassov","year":"2004","journal-title":"Curr. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/j.cub.2006.08.001","article-title":"mSin1 is necessary for Akt\/PKB phosphorylation, and its isoforms define three distinct mTORC2s","volume":"16","author":"Frias","year":"2006","journal-title":"Curr. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cell.2006.08.033","article-title":"SIN1\/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity","volume":"127","author":"Jacinto","year":"2006","journal-title":"Cell"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1101\/gad.1461206","article-title":"Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity","volume":"20","author":"Yang","year":"2006","journal-title":"Genes Dev."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Zhou, Q., Doherty, J., Akk, A., Springer, L.E., Fan, P., Spasojevic, I., Halade, G.V., Yang, H., Pham, C.T.N., and Wickline, S.A. (2022). Safety Profile of Rapamycin Perfluorocarbon Nanoparticles for Preventing Cisplatin-Induced Kidney Injury. Nanomaterials, 12.","DOI":"10.3390\/nano12030336"},{"key":"ref_27","unstructured":"Mayer, J., and Donnelly, T.M. (2013). Clinical Veterinary Advisor: Birds and Exotic Pets, Elsevier."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: Molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00405-022-07572-8","article-title":"Radiotherapy plus cetuximab or cisplatin in head and neck squamous cell carcinoma: An updated systematic review and meta-analysis of randomized controlled trials","volume":"280","author":"Li","year":"2023","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"i58","DOI":"10.1093\/annonc\/mdw088","article-title":"Optimal primary therapy of ovarian cancer","volume":"27","author":"Bookman","year":"2016","journal-title":"Ann. Oncol."},{"key":"ref_31","first-page":"e3586","article-title":"Cure of Oligometastatic Classic Biphasic Pulmonary Blastoma Using Aggressive Tri-modality Treatment: Case Series and Review of the Literature","volume":"10","author":"Lewis","year":"2018","journal-title":"Cureus"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1200\/JCO.2017.72.4401","article-title":"Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non-Small-Cell Lung Cancers: American Society of Clinical Oncology\/Cancer Care Ontario Clinical Practice Guideline Update","volume":"35","author":"Kris","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1158\/1535-7163.MCT-08-0840","article-title":"Platinum neurotoxicity pharmacogenetics","volume":"8","author":"McWhinney","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2217\/pgs.11.48","article-title":"Pharmacogenomics of cisplatin-induced ototoxicity","volume":"12","author":"Mukherjea","year":"2011","journal-title":"Pharmacogenomics"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/1097-0142(197410)34:4<1030::AID-CNCR2820340411>3.0.CO;2-C","article-title":"Platinum nephrotoxicity","volume":"34","author":"Hardaker","year":"1974","journal-title":"Cancer"},{"key":"ref_36","first-page":"1675","article-title":"Comparative nephrotoxicity of platinum cancer chemotherapeutic agents","volume":"60","author":"Ward","year":"1976","journal-title":"Cancer Treat. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/1097-0142(197704)39:4<1362::AID-CNCR2820390403>3.0.CO;2-N","article-title":"The renal pathology in clinical trials of cis-platinum (II) diamminedichloride","volume":"39","author":"Hayes","year":"1977","journal-title":"Cancer"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.bbagen.2013.12.007","article-title":"Albumin fusion renders thioredoxin an effective anti-oxidative and anti-inflammatory agent for preventing cisplatin-induced nephrotoxicity","volume":"1840","author":"Kodama","year":"2014","journal-title":"Biochim. Biophys. Acta (BBA) Gen. Subj."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1093\/ndt\/12.12.2478","article-title":"Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application","volume":"12","author":"Kuhlmann","year":"1997","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"F505","DOI":"10.1152\/ajprenal.90545.2008","article-title":"The copper transporter Ctr1 contributes to cisplatin uptake by renal tubular cells during cisplatin nephrotoxicity","volume":"296","author":"Pabla","year":"2009","journal-title":"Am. J. Physiol.-Renal Physiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/S0002-9440(10)61234-5","article-title":"Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2","volume":"167","author":"Ciarimboli","year":"2005","journal-title":"Am. J. Pathol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1096\/fj.13-237388","article-title":"Rapamycin nanoparticles target defective autophagy in muscular dystrophy to enhance both strength and cardiac function","volume":"28","author":"Bibee","year":"2014","journal-title":"FASEB J."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1002\/mrm.26985","article-title":"Quantification of vascular damage in acute kidney injury with fluorine magnetic resonance imaging and spectroscopy","volume":"79","author":"Moore","year":"2018","journal-title":"Magn. Reson. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1002\/mrm.24851","article-title":"Assessing intrarenal nonperfusion and vascular leakage in acute kidney injury with multinuclear 1H\/19F MRI and perfluorocarbon nanoparticles","volume":"71","author":"Hu","year":"2014","journal-title":"Magn. Reson. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ctrv.2011.09.002","article-title":"Endothelial vascular toxicity from chemotherapeutic agents: Preclinical evidence and clinical implications","volume":"38","author":"Soultati","year":"2012","journal-title":"Cancer Treat. Rev."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000226049","article-title":"Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy","volume":"42","author":"Licciardello","year":"1985","journal-title":"Oncology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1111\/j.1538-7836.2007.02788.x","article-title":"Chemotherapy-induced thrombin generation via procoagulant endothelial microparticles is independent of tissue factor activity","volume":"5","author":"Lechner","year":"2007","journal-title":"J. Thromb. Haemost. JTH"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s11805-011-0566-8","article-title":"Influence of Vein Injury in Different Methods of Chemotherapy in Mice","volume":"8","author":"Li","year":"2011","journal-title":"Clin. Oncol. Cancer Res."},{"key":"ref_49","first-page":"443","article-title":"Comprehensive Characterization of the Vascular Effects of Cisplatin-Based Chemotherapy in Patients with Testicular Cancer","volume":"2","author":"Cameron","year":"2020","journal-title":"J. Am. Coll. Cardiol. CardioOncol."},{"key":"ref_50","first-page":"247","article-title":"Vascular damage in testicular cancer patients: A study on endothelial activation by bleomycin and cisplatin in vitro","volume":"23","author":"Meijer","year":"2010","journal-title":"Oncol. Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/sj.bjc.6690449","article-title":"Synergistic induction of ICAM-1 expression by cisplatin and 5-fluorouracil in a cancer cell line via a NF-\u03baB independent pathway","volume":"80","author":"Takizawa","year":"1999","journal-title":"Br. J. Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.gene.2018.06.017","article-title":"ATF3 and PRAP1 play important roles in cisplatin-induced damages in microvascular endothelial cells","volume":"672","author":"Li","year":"2018","journal-title":"Gene"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"137072","DOI":"10.1155\/2009\/137072","article-title":"Mediators of inflammation in acute kidney injury","volume":"2009","author":"Akcay","year":"2009","journal-title":"Mediat. Inflamm."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejca.2021.10.010","article-title":"The association of cisplatin pharmacokinetics and skeletal muscle mass in patients with head and neck cancer: The prospective PLATISMA study","volume":"160","author":"Chargi","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"105522","DOI":"10.1016\/j.oraloncology.2021.105522","article-title":"Weight loss and its impact on outcome in head and cancer patients during chemo-radiation","volume":"122","author":"Singh","year":"2021","journal-title":"Oral Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ygyno.2007.06.010","article-title":"Weight change during chemotherapy as a potential prognostic factor for stage III epithelial ovarian carcinoma: A Gynecologic Oncology Group study","volume":"107","author":"Hess","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ijrobp.2013.07.033","article-title":"Impact of weight change during the course of concurrent chemoradiation therapy on outcomes in stage IIIB non-small cell lung cancer patients: Retrospective analysis of 425 patients","volume":"87","author":"Topkan","year":"2013","journal-title":"Int. J. Radiat. Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/path.2697","article-title":"Autophagy: Cellular and molecular mechanisms","volume":"221","author":"Glick","year":"2010","journal-title":"J. Pathol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Awadalla, A., Hussein, A.M., El-Far, Y.M., El-Senduny, F.F., Barakat, N., Hamam, E.T., Abdeen, H.M., El-Sherbiny, M., Serria, M.S., and Sarhan, A.A. (2022). Rapamycin Improves Adipose-Derived Mesenchymal Stem Cells (ADMSCs) Renoprotective Effect against Cisplatin-Induced Acute Nephrotoxicity in Rats by Inhibiting the mTOR\/AKT Signaling Pathway. Biomedicines, 10.","DOI":"10.3390\/biomedicines10061295"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e12627","DOI":"10.1111\/cpr.12627","article-title":"Ginsenoside Rb3 provides protective effects against cisplatin-induced nephrotoxicity via regulation of AMPK-\/mTOR-mediated autophagy and inhibition of apoptosis in vitro and in vivo","volume":"52","author":"Xing","year":"2019","journal-title":"Cell Prolif."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"14370","DOI":"10.1096\/fj.201901712R","article-title":"Lithium targeting of AMPK protects against cisplatin-induced acute kidney injury by enhancing autophagy in renal proximal tubular epithelial cells","volume":"33","author":"Bao","year":"2019","journal-title":"FASEB J."},{"key":"ref_62","first-page":"1502","article-title":"Rapamycin Is Not Protective against Ischemic and Cisplatin-Induced Kidney Injury","volume":"84","author":"Andrianova","year":"2019","journal-title":"Biochemistry"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0163-7258(87)90012-X","article-title":"Quantitative estimation of cisplatin-induced DNA interstrand cross-links and their repair in mammalian cells: Relationship to toxicity","volume":"34","author":"Roberts","year":"1987","journal-title":"Pharmacol. Ther."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0021-9258(17)42175-2","article-title":"Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair","volume":"269","author":"Chu","year":"1994","journal-title":"J. Biol. Chem."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.ki.5002256","article-title":"The pathological role of Bax in cisplatin nephrotoxicity","volume":"72","author":"Wei","year":"2007","journal-title":"Kidney Int."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1161\/CIRCRESAHA.116.305421","article-title":"Regulated necrotic cell death: The passive aggressive side of Bax and Bak","volume":"116","author":"Karch","year":"2015","journal-title":"Circ. Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ccc.2008.12.007","article-title":"Oxygen therapeutics: Perfluorocarbons and blood substitute safety","volume":"25","author":"Cohn","year":"2009","journal-title":"Crit. Care Clin."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1097\/00000542-199911000-00009","article-title":"Perflubron emulsion delays blood transfusions in orthopedic surgery. European Perflubron Emulsion Study Group","volume":"91","author":"Spahn","year":"1999","journal-title":"Anesthesiology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/00000441-199403000-00009","article-title":"Role of the perfluorocarbon Fluosol-DA in coronary angioplasty","volume":"307","author":"Kerins","year":"1994","journal-title":"Am. J. Med. Sci."},{"key":"ref_70","first-page":"537","article-title":"Perfluorocarbon liquid in traumatic vitreous hemorrhage and retinal detachment","volume":"24","author":"Desai","year":"1993","journal-title":"Ophthalmic Surg."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1053\/j.ackd.2013.08.004","article-title":"Perfluorocarbon nanoparticles for physiological and molecular imaging and therapy","volume":"20","author":"Chen","year":"2013","journal-title":"Adv. Chronic Kidney Dis."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1007\/s10439-009-9643-z","article-title":"Perfluorocarbon nanoemulsions for quantitative molecular imaging and targeted therapeutics","volume":"37","author":"Kaneda","year":"2009","journal-title":"Ann. Biomed. Eng."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.2217\/nnm.15.26","article-title":"Molecular imaging of atherosclerosis with nanoparticle-based fluorinated MRI contrast agents","volume":"10","author":"Palekar","year":"2015","journal-title":"Nanomedicine"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.copbio.2004.11.001","article-title":"Targeted contrast agents for magnetic resonance imaging and ultrasound","volume":"16","author":"Morawski","year":"2005","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/978-1-0716-0978-1_31","article-title":"Fluorine (19F) MRI to Measure Renal Oxygen Tension and Blood Volume: Experimental Protocol","volume":"2216","author":"Hu","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/mrm.21795","article-title":"Nanoparticle pharmacokinetic profiling in vivo using magnetic resonance imaging","volume":"60","author":"Neubauer","year":"2008","journal-title":"Magn. Reson. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1161\/01.ATV.0000235724.11299.76","article-title":"Endothelial \u03b1v\u03b23 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis","volume":"26","author":"Winter","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/mrm.21794","article-title":"Detection of targeted perfluorocarbon nanoparticle binding using 19F diffusion weighted MR spectroscopy","volume":"60","author":"Waters","year":"2008","journal-title":"Magn. Reson. Med."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/7\/6086\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:01:44Z","timestamp":1760122904000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/7\/6086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,23]]},"references-count":78,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["ijms24076086"],"URL":"https:\/\/doi.org\/10.3390\/ijms24076086","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,23]]}}}